Increased incidence of melanoma in situ in Denmark from 1997 to 2011: results from a nationwide population-based study
- PMID: 24892956
- DOI: 10.1097/CMR.0000000000000092
Increased incidence of melanoma in situ in Denmark from 1997 to 2011: results from a nationwide population-based study
Abstract
The incidence of malignant melanoma has increased markedly among white populations in the recent decades. This may suggest that the incidence of melanoma in situ (MIS), the precursor of malignant melanoma, has also increased; however, few studies have assessed the incidence of MIS drawing on large population-based data sets. The present study aimed to assess MIS incidence trends in Denmark from 1997 to 2011. Data on MIS overall and on the histological subtypes superficial spreading MIS (SSM) and lentigo maligna (LM) were obtained from the Danish Nationwide Registry of Pathology. We calculated overall and age-specific incidence rates for both sexes, age-adjusted according to the world standard population. The average annual percentage change (AAPC) and 95% confidence intervals were calculated using log-linear Poisson models. Among both sexes, a high continued increase in MIS incidence rates overall and in that of the histological subtypes SSM and LM were observed during the period from 1997 to 2011. During this period, the age-adjusted MIS incidence rate increased from 2.6 to 8.1 cases among women and from 1.4 to 5.6 cases among men per 100 000 person-years. For both sexes, the highest AAPC in MIS incidence was observed during the most recent 5-year calendar period. A markedly higher AAPC was observed for SSM than for LM during the most recent 5-year calendar period for both sexes. The marked increase in incidence of MIS during the last 5 years of the period may indicate a growing awareness of skin cancer among the general Danish population and more frequent excision of suspicious skin lesions.
Similar articles
-
The steadily growing problem of lentigo maligna and lentigo maligna melanoma in Australia: Population-based data on diagnosis and management.Australas J Dermatol. 2019 May;60(2):118-125. doi: 10.1111/ajd.12928. Epub 2018 Oct 9. Australas J Dermatol. 2019. PMID: 30302753
-
Epidemiology of Lentigo Maligna and Lentigo Maligna Melanoma in the Netherlands, 1989-2013.J Invest Dermatol. 2016 Oct;136(10):1955-1960. doi: 10.1016/j.jid.2016.06.014. Epub 2016 Jun 24. J Invest Dermatol. 2016. PMID: 27349862
-
Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990-2000.J Invest Dermatol. 2005 Oct;125(4):685-91. doi: 10.1111/j.0022-202X.2005.23852.x. J Invest Dermatol. 2005. PMID: 16185266
-
Cutaneous melanoma in situ: a review.Clin Exp Dermatol. 2025 Feb 24;50(3):529-536. doi: 10.1093/ced/llae465. Clin Exp Dermatol. 2025. PMID: 39449583 Review.
-
Lentigo maligna melanoma--the review.Coll Antropol. 2010 Apr;34 Suppl 2:299-301. Coll Antropol. 2010. PMID: 21305747 Review.
Cited by
-
Dermoscopy Use Leads to Earlier Cutaneous Melanoma Diagnosis in Terms of Invasiveness and Size? A Single-Center, Retrospective Experience.J Clin Med. 2022 Aug 21;11(16):4912. doi: 10.3390/jcm11164912. J Clin Med. 2022. PMID: 36013151 Free PMC article.
-
Lentigo maligna and lentigo maligna melanoma: contemporary issues in diagnosis and management.Melanoma Manag. 2015 May;2(2):171-178. doi: 10.2217/mmt.15.3. Epub 2015 May 18. Melanoma Manag. 2015. PMID: 30190846 Free PMC article. Review.
-
Trend Shifts in Age-Specific Incidence for In Situ and Invasive Cutaneous Melanoma in Sweden.Cancers (Basel). 2021 Jun 7;13(11):2838. doi: 10.3390/cancers13112838. Cancers (Basel). 2021. PMID: 34200396 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical